Management Presentation: Biosimilar Pipeline and Margin Improvement Strategy

Attractive market fundamentals | Leadership and scale | Multiple growth drivers Margin improvement | Attractive financial outlook | Compelling sustainability story D Leveraging strategic partnerships to drive long-term growth Key partners Just EVOTEC BIOLOGICS V NOVARTIS Accessing best-in-class Biosimilars technical and manufacturing capabilities polpharma biologics Securing long-term Biosimilars manufacturing capacity SAMSUNG BIOEPIS Note: The third-party trademarks above are property of their respective owners 16 Management Presentation Adding new commercial assets Sandoz as partner of choice due to commercial scale, development and regulatory capabilities SANDOZ

View entire presentation